Mitochondrial calcium has been postulated to regulate a wide range of processes from bioenergetics to cell death. Here, we characterize a mouse model that lacks expression of the recently discovered mitochondrial calcium uniporter (MCU). Mitochondria derived from MCU −/− mice have no apparent capacity to rapidly uptake calcium. Whereas basal metabolism seems unaffected, the skeletal muscle of MCU −/− mice exhibited alterations in the phosphorylation and activity of pyruvate dehydrogenase. In addition, MCU −/− mice exhibited marked impairment in their ability to perform strenuous work. We further show that mitochondria from MCU −/− mice lacked evidence for calcium-induced permeability transition pore (PTP) opening. The lack of PTP opening does not seem to protect MCU −/− cells and tissues from cell death, although MCU −/− hearts fail to respond to the PTP inhibitor cyclosporin A. Taken together, these results clarify how acute alterations in mitochondrial matrix calcium can regulate mammalian physiology.
the identification of this ruthenium red sensitive mitochondrial uniporter remained elusive. That situation changed when two groups recently reported the existence of a transmembrane protein CCDC109A that seemed to fulfil the requirement of the long elusive MCU protein 9, 10 . These groups identified that MCU is a protein with a relative molecular mass of approximately 40,000 (M r 40K) that is widely expressed and localizes, as expected, to the IMM (refs 9,10) .
Although the molecular identity of MCU was unknown until recently, the role of mitochondrial calcium has been intensively studied over the past four decades. These studies have collectively demonstrated that mitochondrial calcium acutely regulates a range of mitochondrial enzymes involved in either the supply of reducing equivalents 11 or metabolic substrates 12 , or electron transport 13 . Together, these observations supported the notion that MCU-dependent entry of calcium represented a central component of metabolic regulation. Indeed, it had been known that cells and tissues seem capable of exquisitely matching the rate of ATP production with ATP utilization such that even with large fluctuations in power output, levels of metabolic intermediates such as ATP, ADP and P i remain −/− mice (n = 3 animals per genotype, mean ± s.e.m., * P < 0.05, * * P < 0.01 by analysis of variance compared with WT expression). (d) MCU protein expression in various tissues using a rabbit polyclonal antibody generated against the C terminus of MCU. Tubulin is used as a loading control. (e) Assessment of mitochondrial calcium levels using the fluorescent mitochondrial calcium sensor Fluo-4FF. Calcium addition over the physiological (micromolar) range results in increasing calcium levels in mitochondria isolated from WT skeletal muscle. This uptake in WT mitochondria is inhibited by Ru360 addition. MCU −/− mitochondria lack any demonstrable uptake. Shown is one experiment that is representative of three similar experiments. Inset: western blot analysis of MCU expression in purified WT and MCU −/− mitochondria with cytochrome C oxidase subunit IV (isoform 1) used as a loading control. Arrows indicate calcium addition. (f) Similar experiment performed using cardiac mitochondria. At higher Ca 2+ concentrations, there is a small non-Ru360-inhibitable increase in Fluo-4FF fluorescence in MCU −/− mitochondria observed. (g) Parallel assessment of extramitochondrial calcium measurements demonstrating that only WT cardiac mitochondria seem capable of calcium uptake. Uncropped images of blots are shown in Supplementary Fig. 9 . unchanged 14, 15 . This has been extensively studied in tissues such as the heart or skeletal muscle that see large and acute changes in their energy utilization when, for instance, the organism goes from a resting state to a full speed sprint. Under these conditions, it has been widely believed that the entry of mitochondrial calcium augments mitochondrial ATP production to acutely match the rapid increase in ATP demand 11, [16] [17] [18] . Although the entry of small amounts of calcium may have beneficial effects for metabolic homeostasis, there is a significant amount of data demonstrating that the uptake of large amounts of calcium can induce cell death 19, 20 . The basis for this phenomenon involves opening of the permeability transition pore (PTP) . Although the precise molecular make-up of the PTP has remained elusive, evidence suggests that the entry of calcium through an MCU-dependent mechanism is the central mediator of PTP opening [21] [22] [23] . Once opened, the PTP results in depolarization of the IMM leading to collapse of the mitochondrial membrane potential and thus inhibition of electron transport and mitochondrial-dependent ATP production. This has led to the widespread belief that targeting this pathway, including the development of potential inhibitors of MCU, might be a robust strategy to block injury that occurs in a wide array of clinically important disease processes from ischaemia to neurodegeneration 19, 24 . Taken together, there is a long and extensive literature suggesting that dynamic alterations in mitochondrial calcium play a central role in a wide range of physiological conditions from acute metabolic regulation to determining the threshold for cell death. Nonetheless, most of these studies have been hampered by the inability to directly alter in vivo mitochondrial calcium uptake. Although ruthenium red and some of its derivatives readily block MCU function, these agents cannot reliably enter cells, thus limiting this as an approach to dynamically regulate calcium uptake in intact tissues 25 . However, the recent identification of MCU provides a potential genetic approach to directly test many of these concepts. Here, we have generated and characterized mice lacking MCU expression to gain further insight into the role of mitochondrial calcium in mammalian physiology.
RESULTS

MCU regulates calcium uptake
To determine the physiological functions of MCU, we constructed a mouse model using a gene trap strategy in which a retroviral trapping vector was integrated into the first intron of the CCDC109A locus ( Supplementary Fig. S1a,b) . Although slightly smaller (Fig. 1a,b) , organ weight was proportional to body size and overall body composition was indistinguishable between young and old wild type (WT) and MCU −/− mice ( Supplementary Fig. S1c,d ). Further examination of MCU −/− embryonic and adult tissues by electron microscopy revealed no obvious abnormalities in mitochondrial number or morphology ( Supplementary Fig. S2a ). Although mice generated using a gene trap strategy sometimes exhibit hypomorphic expression of the targeted gene, there was little evidence of MCU messenger RNA expression (Fig. 1c) . Similarly, western blot analysis using antibodies recognizing either amino-terminal or carboxyterminal regions of the protein failed to detect any MCU protein expression in tissues derived from MCU −/− mice ( Fig. 1d and Supplementary Fig. S2,b,c) .
We next sought to assess whether the absence of MCU expression altered mitochondrial calcium uptake. When purified mitochondria isolated from skeletal muscle of adult WT and MCU −/− mice were loaded with the calcium-sensitive dye Fluo-4FF, WT mitochondria exhibited robust calcium uptake over a range of physiologically relevant extramitochondrial calcium concentrations (Fig. 1e) . This uptake was inhibited in WT mitochondria by the addition of the potent ruthenium red subcomponent, Ru360. However, MCU −/− skeletal muscle mitochondria, which lacked detectable MCU expression (Fig. 1e, inset) , exhibited no appreciable calcium uptake over a range of physiological calcium concentrations. Further experiments performed with heart mitochondria revealed similar findings, although with cumulative additions of micromolar concentrations of calcium, we did note that MCU −/− cardiac mitochondria marginally increased their Fluo-4FF fluorescence (Fig. 1f) , but this signal seemed to represent nonspecific leakage of dye out of the mitochondrial matrix as indicated by rapid quenching of the fluorescent signal with EGTA ( Supplementary Fig. S3a,b) . We performed parallel experiments using Calcium Green-5N to measure extramitochondrial calcium levels (Fig. 1g) . In these experiments, calcium addition to WT cardiac mitochondria resulted in a rapid increase in Calcium Green-5N fluorescence followed by a slower decline in the fluorescence intensity of the calcium sensor (Fig. 1g ). This slower decrease in fluorescence after calcium addition is consistent with the known buffering capacity of mitochondria to uptake cytosolic calcium. At higher concentrations of calcium (≥15 µM), buffering capacity is eventually exceeded and stored mitochondrial calcium is released into the extramitochondrial space. Over the same range of calcium concentration, MCU −/− mitochondria did not demonstrate evidence for either mitochondrial uptake or release.
To further analyse the function of MCU within intact cells, we generated primary mouse embryonic fibroblasts (MEFs) from WT and MCU −/− embryos. Functional assessment revealed that when calcium was added to permeabilized MEFs, there was an initial rapid spike in Calcium Green-5N fluorescence intensity (Fig. 2a) , which was followed by a slower decline in the fluorescence intensity of the cytosolic calcium sensor. As described above, this decline in fluorescence corresponds to mitochondrial calcium uptake. In permeablized WT MEFs, in the presence of ER calcium uptake inhibition, mitochondrial uptake continued until the calcium retention capacity of the mitochondria was exceeded. At this point (for example, the fourth addition of calcium in Fig. 2a) , any further increase in extramitochondrial calcium resulted in a large rise in measured fluorescence. This terminal, large fluorescent increase indicates the irreversible release of mitochondrial calcium stores and is commonly used as an index of PTP opening (similar to Fig. 1g ). In contrast, calcium addition to MCU −/− MEFs resulted in a staircase profile consistent with the inability of MCU −/− mitochondria to rapidly uptake calcium (Fig. 2a) . The profile seen in MCU −/− MEFs was similar to what is observed when WT MEFs were treated with ruthenium red (Fig. 2b) . Retroviral-mediated reconstitution of WT MCU expression restored mitochondrial calcium uptake in MCU −/− MEFs (Fig. 2c,d ). In contrast, a mutant of MCU where the critical acidic linker region was mutated at amino acids 261 and 264 was unable to reconstitute calcium uptake when expressed in MCU −/− cells. To assess mitochondrial calcium uptake in a more physiological context, we isolated adult cardiac myocytes from WT and MCU −/− mice. Consistent with previous results 26 , in WT myocytes loaded with the mitochondrial-targeted calcium-sensitive dye Rhod-2 in the presence of manganese added to quench any cytosolic signal, isoproterenol addition stimulated a measurable rise in mitochondrial calcium levels (Fig. 3a) . This response was absent in cardiac myocytes obtained from MCU −/− mice. Mitochondrial calcium levels were also unchanged in MCU −/− myocytes treated with agents (KCl and caffeine) that have been shown to directly increase cytosolic calcium ( Supplementary Fig. S3c,d) . Similarly, analysis of MEFs engineered to express a mitochondrial-targeted aequorin construct and then stimulated with histamine revealed that ligand-stimulated mitochondrial calcium fluxes were markedly diminished in MCU −/− cells (Fig. 3b) . In contrast, histamine-induced cytosolic calcium changes were similar (Fig. 3c) . Thus, as we observed with isolated −/− mitochondria (P value is not significant; n = 3 independent experiments). (d) Average total body oxygen consumption in WT and MCU −/− mice during day and night conditions (n = 5 WT and n = 6 MCU −/− mice; all mice were female; P value is not significant between genotypes). All pooled data represents mean ± s.e.m.
mitochondria, cells derived from MCU
−/− mice seem unable to rapidly uptake calcium.
MCU and metabolism
We next sought to ascertain the role of MCU in basal metabolism. Surprisingly, when we analysed oxygen consumption of MCU
−/−
MEFs under basal conditions, we noted no detectable difference from WT MEFs using a variety of potential metabolic substrates ( Fig. 4a and Supplementary Fig. S4a ). This lack of a discernible difference may reflect the low basal energetic requirement for MEFs in culture, although the effect of treatment with mitochondrial membrane depolarizing agents such as FCCP suggests that WT and MCU −/− MEFs had a similar maximal oxidative capacity. To further pursue the absence or presence of a basal metabolic phenotype, we isolated mitochondria from WT and MCU −/− mice. When purified mitochondria were given glutamate and malate as a substrate, we noted that MCU −/− and WT mitochondria exhibited similar levels of respiration (Fig. 4b) . Similarly, the response to ADP and the respiratory control ratio (state 3/state 4) were indistinguishable (Fig. 4b,c) . Furthermore, metabolic assessment of total body basal oxygen consumption was not altered in MCU −/− mice (Fig. 4d) . Finally, in contrast to what has been observed in cell culture models using primarily immortalized and transformed cells 27 , we found no clear evidence of increased levels of autophagy in primary cells or tissues lacking MCU expression ( Supplementary Fig. S4b ,c). Taken together, these results demonstrate that basal metabolism is not markedly altered in the absence of MCU expression.
It has been known for nearly 50 years that calcium, like ADP and FCCP, can induce mitochondrial membrane depolarization and thereby transiently stimulate oxygen consumption 28 . Consistent with these past observations, in WT mitochondria, calcium addition resulted in nearly a tenfold increase in mitochondrial respiration (Fig. 5a ). In contrast, no calcium-dependent stimulation was observed in the respiration of mitochondria obtained from MCU −/− mice. Although informative, such experiments using isolated mitochondria and high concentrations of calcium are by nature non-physiological. Thus, to better understand the physiological importance of mitochondrial calcium, we concentrated on the role of MCU in skeletal muscle physiology in vivo. One postulated effect of intramitochondrial calcium is the regulation of key mitochondrial enzymes involved in bioenergetics and metabolic flux. In particular, the phosphorylation of pyruvate dehydrogenase (PDH) is thought to be modulated by the calcium-sensitive phosphatase PDP1 (ref. 29) . We reasoned that MCU −/− mice should allow a direct test of whether PDH is indeed regulated in vivo by these mechanisms. We first measured resting matrix calcium levels in mitochondria isolated from the skeletal muscle of WT and MCU −/− mice. We noted an approximate 75% reduction in basal matrix calcium levels in the mitochondria of including the extensor digitorum longus (EDL) representing glycolytic/fast twitch fibres, the soleus (SOL) that is predominantly oxidative/slow twitch and the gastrocnemius (GN) that is a mix of fast and slow twitch. (e) Skeletal muscle PDH activity in units of milli optical density (mOD) for WT and MCU −/− mice after a 16 h fast ( * P < 0.05; n = 3 mice per genotype). (f) Serum lactate levels in WT and MCU −/− male mice under fed conditions or after 16 h of starvation (n = 7 WT and n = 6 MCU −/− , * P < 0.05 by t -test). (g) Metabolomic analysis of skeletal muscle demonstrating levels of various TCA cycle intermediates in mice that were starved overnight (n = 3 male mice per genotype). There was a trend for increased lactate levels in the MCU −/− muscle. All pooled data represents mean ± s.e.m. Uncropped images of blots are shown in Supplementary Fig. 9 .
MCU
−/− mice (Fig. 5b) . Using a phospho-specific PDH E1 subunit antibody, we next analysed the level of PDH phosphorylation in three pairs of WT and MCU −/− mice. Consistent with the role for the calcium-sensitive phosphatase PDP1 regulating PDH phosphorylation, lower levels of matrix calcium in the MCU −/− mice led to markedly increased levels of PDH phosphorylation in these animals (Fig. 5c ). We noted these changes across a variety of muscle types including skeletal muscle groups that were either fast twitch, slow twitch or mixed fibres (Fig. 5d) . These phosphorylation differences were most evident under starved conditions and largely disappeared when the animals were re-fed (Supplementary Figs S5a-c) . Similarly, direct addition of calcium to WT mitochondria led to a rapid reduction in PDH E1 phosphorylation, a response not evident in isolated MCU −/− mitochondria ( Supplementary Fig. S5d ). Previous results have indicated that this phosphorylation change on the E1 subunit is known to negatively regulate PDH activity 30 . Consistent with these past results, PDH activity was significantly reduced in the skeletal muscle of starved MCU −/− mice, whereas citrate synthase activity was not altered (Fig. 5e and Supplementary  Fig. S5e ). Finally, a decrease in PDH activity often correlates with a rise in serum lactate levels. We noted that MCU −/− mice indeed had a significantly elevated serum lactate level (Fig. 5f ). Direct measurement of muscle lactate levels demonstrated a similar trend, whereas other tricarboxylate acid (TCA) metabolites were not altered (Fig. 5g) .
MCU regulates skeletal muscle work
The entry of calcium into the mitochondria during various physiological stresses is thought to increase mitochondrial energy production 11 . We next designed a number of functional tests that required a rapid increase in skeletal muscle work load. When we assessed skeletal muscle peak performance by placing mice on a rapid, steep treadmill, we observed a statistically significant impairment in the exercise capacity of MCU −/− mice (Fig. 6a) . Similarly, when we assessed forearm grip strength, a measure of predominantly isometric muscle contraction, we also noted a small, but significant decrease in the strength of MCU −/− mice (Fig. 6b ). This defect was more pronounced when we measured the ability of the mice to perform a pull up manoeuvre that requires concentric muscle contraction and hence increased power output (Fig. 6c) . These observed defects in the ability of MCU −/− animals to generate maximal power output were not due to any apparent alterations in skeletal muscle fibre composition ( Fig. 6d and Supplementary Fig. S6 ).
The role of MCU in cell death
The opening of the PTP causes a rapid inflow of solutes inducing mitochondrial swelling and can be readily monitored by a number of approaches including a rapid fall in absorbance 31 . Consistent with previous results, the addition of extramitochondrial calcium to WT cardiac mitochondria induced PTP opening (Fig. 7a) . For WT mitochondria, this opening was inhibited by addition of either cyclosporin A (CsA) or Ru360. In contrast, MCU −/− mitochondria isolated from either liver or heart exhibited no evidence of PTP opening even after exposure to high levels of calcium for prolonged periods of time (Fig. 7a,b and Supplementary Fig. S7a ). As such, these observations are consistent with our previous observations in permeabilized cells (see Fig. 2a ) and demonstrate that MCU is required for calcium-induced PTP opening.
We next sought to understand the physiological importance of these observations. We took MCU −/− or WT MEFs and exposed them to a range of potential inducers of cell death. These agents included hydrogen peroxide as a prototypical example of oxidative stress; the ER stress inducing agent tunicamycin; the chemotherapeutic and DNA damaging agent doxorubicin; C2-ceramide, an agent that can activate both apoptotic and necrotic pathways; and thapsigargin, which triggers cell death by interfering with ER calcium uptake. We monitored cell death using the combination of annexin V and staining. Although all of these agents were effective at inducing cell death, we noted no difference in the kinetics or magnitude of cell death in MEFs with or without MCU expression (Fig. 7c) . We also noted that the release of cytochrome C from the mitochondria into the cytosol was not affected by MCU expression, nor did we observe a significant difference in cytosolic calcium levels during cell death (Fig. 7d and Supplementary  Fig. S7b,c) . For both tunicamycin and doxorubicin we also measured the degree of caspase-3 activity. Again, we noted indistinguishable levels of caspase-3 activation in WT and MCU −/− cells (Fig. 7e) . Finally, to assess whether similar effects were observed in tissues and organs, we subjected hearts of WT and MCU −/− mice to ischaemia-reperfusion injury. When the degree of injury was assessed by functional measurements such as the post-ischaemic recovery in the rate pressure product or by pathological measurements such as direct assessment of the infarct area, our analysis revealed that MCU −/− mice exhibited no evidence for protection from ischaemia-reperfusion-mediated injury (Fig. 8a,b) . Similarly, the level of apoptosis and the magnitude of ischaemic contracture was equivalent in WT and MCU −/− hearts subjected to ischaemia-reperfusion injury ( Supplementary Fig. S8a,b) . Interestingly, whereas, as expected, the PTP inhibitor CsA provided significant protection to WT hearts 32 , this agent had no demonstrable effect on MCU −/− hearts (Fig. 8a,b) .
DISCUSSION
In summary, we provide an in vivo description of the physiological effects seen in the absence of MCU expression. Remarkably, although mitochondria and cells from MCU −/− mice lack evidence for highcapacity calcium uptake, these animals are grossly normal. Although this result is unexpected, it should be noted that a previous study found no significant organ pathology following continuous short interfering RNA (siRNA)-mediated knockdown of MCU in the liver 9 . Furthermore, few discernible phenotypes were observed in mice genetically deficient for myoglobin, creatine kinase or creatine, molecules that were all originally thought to be absolutely essential for cardiac and skeletal muscle bioenergetics [33] [34] [35] . Indeed, in the context of the whole animal, the absence of MCU produces relatively minor alterations in basal energetics. However, we should note that we found a significant reduction, but not a complete absence, of mitochondrial matrix calcium in mice lacking MCU. For instance, in our analysis, matrix calcium seemed to be reduced to about 25% of WT levels in the skeletal muscle mitochondria of starved MCU −/− mice. This non-zero value suggests that alternative mechanisms must exist for calcium entry, although on the basis of our cellular and isolated mitochondrial studies; the high capacity, rapid entry mode that occurs through the uniporter is clearly absent. It is conceivable that these slower and presumably low capacitance mechanisms might allow for some physiological adaptation over time. (e) Caspase-3 activity was measured under basal conditions or 24 h after treatment with tunicamycin or doxorubicin (P value is not significant; n = 3). All pooled data represent mean ± s.e.m. Uncropped images of blots are shown in Supplementary Fig. 9 .
We also observed that although MCU −/− mitochondria lacked evidence for calcium-induced PTP opening, the absence of MCU expression did not result in a demonstrable alteration in the magnitude of in vitro or in vivo cell death. Previous results with transient manipulation had suggested that altering MCU expression modulated the sensitivity to cell death in many 10, 36 but not all 37 cellular systems. Interestingly, we observed that although the absence of MCU did not alter the magnitude of cell death, MCU −/− hearts were insensitive to CsA treatment. One interpretation is that in the absence of MCU, additional CsA-independent and calcium-independent cell death pathways emerge and predominate. Interestingly, yeast mitochondria lack an MCU equivalent but still seem to undergo PTP opening, although this event seems to be insensitive to both calcium and CsA 38 .
Finally, although there is unequivocal evidence for the in vitro regulation of mitochondrial dehydrogenase function by calcium 11 , the observation that MCU −/− mice have limited defects in basal metabolism suggests that the in vivo effects of altering matrix calcium may be most important under certain stress conditions. Our results demonstrate that in tissues such as skeletal muscle, which exhibit a large dynamic energetic range, mitochondrial calcium regulates the intrinsic metabolism of the tissue as well as the peak performance. The observation that the defect in maximal skeletal muscle power output of MCU −/− mice is qualitatively similar to what was observed in mice deficient in creatine kinase 34 suggests that this property of skeletal muscle, that is, the ability to rapidly boost and maintain peak power output, is for obvious reasons, under intense evolutionary pressure. 
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
METHODS
Generation of MCU knockout mouse and MEF cells. Two independent
gene-trapped embryonic stem cell clones with confirmed integration within the CCDC109A (MCU) locus were obtained from the Texas A&M Institute of Genomic Medicine (College Station). These two embryonic stem cell clones were microinjected into blastocysts collected from albino C57BL/6 mice (JAX Stock No. 000058), but only one embryonic stem cell clone (ID#: IST11669F8) gave rise to chimaeras signifying germline transmission. As shown in Supplementary Fig. S1 , the retrovirus-based gene-trapping vector, Omnibank Vector 76, was integrated into Intron 1 of the MCU (also known as Ccdc109a) gene. The mutant mouse line was maintained on a mixed background of C57BL/6 and CD1 (Charles River Laboratories). Physiological assessment was performed on 3-5-month-old mice. Body composition (muscle, fat and free fluid) was measured in non-anaesthetized mice using an EchoMRI QMR machine. All mouse embryonic fibroblasts (MEFs) were primary cultures generated from 11.5 to 13.5 day mouse embryos using standard methods. All animal studies were done in accordance and approval of the NHLBI Animal Care and Use Committee.
Mitochondria isolation and metabolic studies. Mitochondria were isolated
by standard differential centrifugation procedures. For cardiac mitochondria, hearts were first minced in mitochondrial isotonic buffer (225 mM mannitol, 75 mM sucrose, 5 mM MOPS, 0.5 mM EGTA and 2 mM taurine (pH 7.25)), and subsequently homogenized using an Ultra-Turrax homogenizer (IKA Labortecknik). To help digest the contractile protein apparatus, trypsin (0.001 g per 0.1 g wet tissue) was added to the homogenate for 5 min on ice. This digestion was stopped by addition of 0.2% BSA. The homogenate was initially centrifuged at 500g and the resulting supernatant was next spun at 11,000g to pellet the mitochondria. The final mitochondrial pellet was resuspended in mitochondrial isotonic buffer + 0.2% BSA.
For isolation of hepatic mitochondria, liver tissue was washed 4X with PBS and then minced in mitochondrial isotonic buffer containing 0.2% BSA. For skeletal muscle mitochondria, the overlying fat and connective tissue was removed, and the skeletal muscle was subsequently minced in mitochondrial isotonic buffer, and then incubated for 2 min in 10 ml of protease buffer (10 ml isotonic buffer and 1 mg nagarse (Sigma, 10.6 U mg −1 )). The digestion as above was stopped by addition of 0.2% BSA. The homogenate was centrifuged and resuspended as above.
Oxygen consumption of isolated mitochondria was measured in a chamber connected to a Clark-type O 2 electrode (Instech) and O 2 monitor (Model 5300, YSI Inc) at 25 • C. Mitochondria were incubated in respiration buffer (120 mM KCl, 5 mM MOPS, 0.1 mM EGTA, 5 mM KH 2 PO 4 and 0.2% BSA). After addition of 10 mM glutamate/2 mM malate, state 3 (maximal) respiration was measured by addition of 0.5 mM ADP, or where indicated, 0.5 mM CaCl 2 . The respiratory control ratio was determined by the state 3/state 4 respiration rates. Measurement of intact cellular respiration was performed using the Seahorse XF24 analyser 39 . Respiration was measured under the basal condition, in the presence of the mitochondrial inhibitor oligomycin (5 µM) and in the presence of the mitochondrial uncoupler FCCP (10 µM) to assess maximal oxidative capacity. Respiration was routinely measured using 25 mM glucose as the extracellular substrate, although further experiments were performed using pyruvate (2 mM) or for cells maintained in the presence of galactose (25 mM).
Total body oxygen consumption and CO 2 production were measured by an open circuit indirect calorimeter (CLAMS, Columbus Instruments). Mice had ad libitum access to food and water and were singly housed one day before the experiment in sealed plastic metabolic cages that were connected to O 2 and CO 2 sensors. After the one day acclimation period, energy expenditure and respiratory exchange ratio were measured for three consecutive days at 30-min intervals.
Calcium retention capacity assay. Calcium uptake in MEFs was assessed using the calcium retention capacity assay as previously described 40 . In brief, WT and MCU −/− MEFs were collected using trypsin and then washed in PBS. The calcium retention capacity assay was performed in a buffer containing 120 mM KCl, 10 mM Tris-HCl at pH 7.4, 5 mM MOPS, 5 mM Na 2 HPO 4 , 10 mM glutamate, 2 mM malate, 0.002% digitonin, and 0.5 mM thapsigargin to inhibit ER calcium uptake. Cytosolic calcium was measured using the fluorescent Ca 2+ indicator Calcium Green-5N (1 µM, Molecular Probes). Experiments were performed in the presence and absence of 3 µM ruthenium red.
Intramitochondrial calcium assays. Direct mitochondrial calcium uptake was measured essentially as previously described 41 . In some experiments, parallel determination of extramitochondrial calcium was performed using Calcium Green-5N as described above. For measurement of mitochondrial Ca 2+ content, skeletal muscle mitochondria were isolated in a buffer containing 225 mM mannitol, 75 mM sucrose, 5 mM MOPS and 2 mM taurine (pH 7.25) that was free of EGTA to avoid Ca 2+ chelation 42 . Mitochondria were pelleted and diluted in 0.6 N HCl (1:10 wt/vol), homogenized and sonicated (2 × 10 s at 40% of maximal power output). Samples were heated for 30 min at 95 • C and then centrifuged for 5 min at 10,000g . The supernatants were recovered and the Ca 2+ content in the supernatants was determined spectrophotometrically using the O-Cresolphthalein Complexone calcium assay kit (Cayman Chemical).
Measurement of mitochondrial [Ca 2+ ] in intact cells. Adult cardiomyocytes
were isolated from hearts of WT and MCU −/− mice as previously described 43 . Myocytes were then attached to Cell-Tak (BD Biosciences)-coated glass-bottom culture dishes. After attachment, myocytes were loaded with 5 µM Rhod2-AM along with 200 µM MnCl 2 to allow selective quenching of the cytosolic fluorescence 44 . After 1 µM isoproterenol, caffeine (20 mM) or KCl (50 mM) treatment, a series of images were captured every 2-5 s by confocal microscopy using a Zeiss LSM 510 microscope (Carl Zeiss) using 561 nm laser excitation. For measurement of mitochondrial calcium in intact MEFs, we infected primary WT and MCU −/− MEFs with an adenovirus that expressed a mitochondrial-targeted aequorin construct. The targeted aequorin was amplified by PCR using a previously described adenovirus (Ad-RIP-mitoAequorin 45 , a gift from A. Wiederkehr, Univ. of Geneva, Switzerland) as template and subcloned into the new adenoviral vector: pShuttle-IRES-hrGFP-2. Aequorin activity was assessed using 5 µM coelenterazine for 2 h in Krebs-Ringer modified buffer (125 mM NaCl, 5 mM KCl, 1 mM Na 3 PO 4 , 1 mM MgSO 4 , 5.5 mM glucose and 20 mM HEPES, at pH 7.4) supplemented with 1 mM CaCl 2 at 37 • C. Light emission after 100 µM histamine stimulation was measured using a luminometer (FLUOstar OPTIMA). At the end of the experiment, 100 µM digitonin and 10 mM CaCl 2 (final concentrations) were added to measure the total aequorin luminescence so as to allow normalization of the data 9 . To measure cytosolic calcium levels in intact MEF cells, cells were loaded with 5 µM Fluo-4 AM for 30 min at room temperature. After 100 µM histamine stimulation, a series of images were captured every 2 s by confocal microscopy using a Zeiss LSM 510 microscope (Carl Zeiss, Germany).
Western blot analysis, MCU expression, autophagy determinations and electron microscopy analysis. For western blot analysis, cells were collected in RIPA buffer (50 mM Tris-HCl, at pH 8.0; 150 mM NaCl; 1% (vol/vol) Nonidet P-40; 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor cocktail (Roche)). For tissue analysis, snap-frozen tissues were homogenized and lysed in RIPA buffer plus phosphatase inhibitor (Sigma). Following transfer to nitrocellulose, membranes were immunoblotted with the indicated primary antibodies including: PDH (#sc-377092, Santa Cruz Biotechnology, 1:500), phospho-PDH Ser293 (#ABS204, Millipore, 1:5,000), tubulin (#T7816, Sigma, 1:10,000), Cox subunit IV (#ab16,056, Abcam, 1:5,000), GAPDH (#ab8245, Abcam, 1:10,000). For detection of MCU protein expression, we generated a rabbit polyclonal antibody using the C-terminal peptide (CLEKYNQLKDAIAQAEMDLKR) conjugated to KLH as an immunogen, or where indicated, a commercial antibody (#HPA016480, Sigma, 1:250) that recognized the N terminus of the protein. To reconstitute MCU expression, full-length MCU human complementary DNA was cloned into the the pBabe-puro retroviral vector. MCU MUT constructs containing the combined D261Q and E264Q mutation were created using Stratagene QuikChange mutagenesis. To determine autophagic flux we analysed primary MEF cells in culture or tissues from WT and MCU −/− mice using antibodies against p62 (#GP62-C, Progen, 1:5,000) or LC3 (#L8918, Sigma, 1:1,000) as previously described 46 . To determine the effects of calcium on PDH phosphorylation in vitro, skeletal muscle mitochondria were washed with respiration buffer without EGTA (120 mM KCl, 5 mM MOPS, 5 mM KH 2 PO 4 and 0.2% BSA) and treated with 500 µM CaCl 2 for 1 min at room temperature. The mitochondria were then lysed and subjected to western DOI: 10.1038/ncb2868 blot analysis for phospho-PDH Ser 293 and total PDH expression. For electron microscopy analysis, embryos or adult organs were placed in fixation solution containing 2.5% glutaraldehyde and 1% paraformaldehyde diluted in 0.12 M sodium cacodylate buffer, at pH 7.4, and imaged using a JEM1400 electron microscope (JEOL USA) equipped with an AMT XR-111 digital camera (Advanced Microscopy Techniques Corp).
Mitochondrial swelling assay. Ca
2+ -induced swelling of isolated mitochondria was measured spectrophotometrically as a decrease in absorbance at 540 nm. Isolated liver or heart mitochondria (100 µg) were resuspended in swelling buffer (120 mM KCl, 10 mM Tris-HCl, 5 mM MOPS, 5 mM Na 2 HPO 4 , 10 mM glutamate, 2 mM malate and 0.1 mM EGTA) in a total volume of 200 µl. Pore opening was induced and detected by the addition of 500 µM of total CaCl 2 while monitoring absorbance at 540 nm. Where indicated, cyclosporin A (0.2 µM) or Ru360 (3.0 µM) was added.
PDH, citrate synthase and lactate determination. PDH activity was measured using the pyruvate dehydrogenase enzyme activity microplate assay kit (Abcam). Serum lactate levels under the fed or starved condition (overnight, 16 h) were measured using the LactatePro analyser (Arkray). Citrate synthase activity was measured in skeletal muscle mitochondria using a commercial kit (ScienCell). One unit of citrate synthase activity is defined as the amount of enzyme required to convert 1.0 µM 5 , 5 -dithiobis 2-nitrobenzoic acid (DTNB) at 25 • C. Quantification of skeletal muscle lactate, succinate, fumarate, malate and citrate was accomplished by GC/MS (ThermoFisher Trace GC Ultra/DSQ II single quadrupole mass spectrometer, Metabolomics Core Facility Sanford-Burnham Medical Research Institute).
Gene expression and muscle fibre typing. Total RNA was extracted by using TRIzol Reagent (Life Technologies). Complementary DNA was prepared using Taqman reverse transcription reagents and oligo-dT primers. Quantitative real-time PCR was performed with 50 ng cDNA on an MxP3005P real-time PCR system (Stratagene) using SsoFast EvaGreen Supermix (Bio-Rad) according to the manufacturer's instructions. The following primer sequences were employed: MCU, forward primer: 5 -GTGCCCTCTGATGACGTGACGG-3 , reverse primer: 5 -ATGACAAGCTTAAAGTCATC-3 ; GAPDH, forward primer: 5 -ATGACATCAAGAAGGTGGTGAAG-3 , reverse primer: 5 -TCCTTGGAGGCCAT-GTAGG-3 ; myosin heavy chain 7 (for Type I), forward: 5 -AATGAGCTGGAGG-CTGAGCAAAAG-3 , reverse primer: 5 -AAGGGCTGTTGCAAAGGCTCCA-3 ; myosin heavy chain 4 (for Type IIa), forward primer: 5 -AAGAACGTGCTGAGGCT-GCAG-3 , reverse primer: 5 -ACAGGACAGTGACAAAGAACGTCAC-3 ; myosin heavy chain 2 (for Type IIb), forward primer: 5 -TGAAGGAGCTTACTTACCAGA-CAG-3 , reverse primer: 5 -CTTCGGTCATTCCACAGCATC-3 ; eukaryotic translation initiation factor EIF35S as a normalization control, forward primer: 5 -CTGAGGATGTGCTGTCTGGGAA-3 , reverse primer: 5 -CCTTTGCCTCCACTTCGGTC-3 . For assessment of muscle fibre type, paraformaldehyde sections were permeabilized with 0.1% Triton-X 100 and stained with goat polyclonal antibodies against myosin heavy chain I (slow) or myosin heavy chain II (fast) fibres (NCL-MHCs and NCL-MHCf, Novocastra, 1:50) as previously described 47 .
Cell death assays. To assess in vitro cell death, early passage (<P4) MEFs were treated with hydrogen peroxide (1 mM), tunicamycin (2 µg ml −1 ), doxorubicin (2 µM), C2-ceramide (100 µM) or thapsigargin (1 µM). After the indicated time, MEF cells were trypsinized and then resuspended in 1× binding buffer (BD Biosciences) at a concentration of 1 × 10 6 cells ml −1 . Then, 100 µl of the solution (1 × 10 5 cells) was transferred to a 5 ml culture tube and stained with 5 µl each of allophycocyanin-annexin V (BD Biosciences) and 50 µg ml −1 propidium iodide (Invitrogen). The cells were gently mixed and incubated at room temperature for 15 min before 300 ml of 1× binding buffer was added to each tube. Samples were analysed by flow cytometry using a LSRII instrument (Becton-Dickinson) with propidium iodine and annexin-V-negative cells indicating viability. To measure the cytosolic calcium levels in cells undergoing cell death, MEF cells were treated with 2 mM H 2 O 2 . At the indicated time, MEFs were incubated with 2 µM Fluo-4 AM (Invitrogen) for 30 min at 37 • C. Cells were then trypsinized, washed twice with PBS and analysed using a FACSCanto flow cytometer (Becton-Dickinson).
Caspase-3 activity was measured using the caspase 3 assay kit (Abcam) according to the manufacturer's directions. For analysis of cytochrome C release, cells were collected at the indicated times by trypsinization and resuspended in 100 µl of mitochondrial isolation buffer (70 mM Tris base, 0.25 M sucrose and 1 mM EDTA, at pH 7.4), 100 µl MES buffer (19.8 mM EDTA, 0.15 M d-mannitol and 19.8 mM MES, at pH 7.4) along with 0.2 mg ml −1 digitonin. The cell lysate was collected and first spun at 900g for 2 min to remove debris. The supernatant was then centrifuged at 13,000g for 5 min to pellet mitochondria. The final supernatant was the cytosolic fraction used for western blot employing an antibody recognizing cytochrome C (#sc-7159, Santa Cruz Biotechnology, 1:1,000). TUNEL staining was performed on ischaemic heart sections using the ApopTag Fluorescein Direct In Situ Apoptosis Detection Kit (Millipore) according to the manufacturer's directions. For quantitative analysis, TUNEL-positive cells from three different sections from each of three different hearts per genotype were counted. The analysis was performed in a blinded fashion and expressed as percentage of TUNEL-positive myocytes in the infarct area.
Exercise testing. Mice were tested for exercise capacity using a high intensity, inclined ramp protocol previously described 47 . This protocol was designed to reflect skeletal muscle performance, rather than aerobic capacity, which is more a function of cardiovascular fitness. In brief, mice were run on a rodent treadmill (Columbus Instruments) at a starting speed of 14 m min −1 and an incline of 20 • . The speed was increased 2 m min −1 every 5 s. Mice ran until failure, which was the last speed in which the mice were capable of staying on the inclined treadmill for the full five seconds. Animal performance was assessed with three trials separated by 24 h. All mice were acclimated and trained to run on the treadmill before initiating the test. The maximum running speed and work was calculated for each of the three trials using the formula: work = body weight (kg) × vertical distance (sin 20 • × distance (m)).
Grip strength and isolated pull up test. Forearm grip strength was evaluated in mice with a Grip Strength Meter (Columbus Instruments). To measure forearm limb grip strength, the mice were held by the base of the tail and allowed to grasp a metal pull bar with their front paws. The experimenter gently and steadily pulled the mice away from the pull bar and the force (kilogram force) applied against the bar at the moment of grip release was recorded as peak tension. Five trials were performed for each mouse with a rest interval of 10 min between trials. Mean peak tension for the five trials was calculated. Grip strength was then normalized for muscle mass as force per gram of muscle. Grams of muscle mass for each animal was determined by measuring body composition (muscle, fat and free fluid) using an Echo MRI QMR machine (Echo MRI-100, Echo Medical System) and using the percentage of muscle mass times the total body weight of the animal.
To determine concentric muscle strength, the above grip strength protocol was modified to isolate the peak force of concentric contraction during a pull up. Washers totalling 7% body weight were applied to the base of the mouse's tail. The mice were trained to grasp the vertically oriented pull bar of the grip strength meter and hang from the bar. This caused the forearm muscles to be in a flexed position eliciting concentric muscle contraction. The experimenter then lightly pinched the distal tail of the mouse eliciting a pull up, as the mouse tried to pull away, from the pressure applied by the experimenter on the tail. The peak force per pull up was recorded with each animal assessed as the average of five trials.
Cardiac ischaemia-reperfusion protocol. The cardiac ischaemia-reperfusion perfusion protocol was performed as previously described 48 . In brief, hearts were quickly isolated and placed in ice-cold Krebs-Heinseleit (KH) buffer (25 mM NaHCO 3 , 120 mM NaCl, 11 mM glucose, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 and 1.75 mM CaCl 2 ) to induce cardiac arrest. The aorta was cannulated on a Langendorff apparatus and the heart was perfused in a retrograde fashion with KH buffer at a constant pressure of 100 cm of water at 37 • C. All hearts were perfused with KH buffer gassed with 95% O 2 and 5% CO 2 . A water-filled latex balloon was inserted into the left ventricle to measure haemodynamic parameters using a PowerLab 2/25 and Chart v5.5 software (AD Instruments). Hearts were subjected to 20 min of equilibration, 20 min of no-flow global ischaemia, followed by 90 min of reperfusion. Recovery of post-ischaemic left ventricular developed pressure and the rate-pressure product were measured. Where indicated cyclosporin A or vehicle was added in the perfusate at a concentration of 0.2 µM for five minutes before ischaemia. At the end of the reperfusion period, hearts were incubated in 1% shown. c) Similar assessment in vivo in both liver and heart tissues under randomly fed conditions.
Again, no consistent differences were observed between genotypes. GAPDH is shown as a loading control.
Supplementary Figure 4 Basal oxygen consumption and authophagic flux in MCU -/-cells and tissues. a) Relative oxygen consumption measured using a Seahorse X-24 analyzer analyzing WT and MCU -/-MEFs under basal conditions with glucose as the substrate (25 mM), or a similar analysis using pyruvate (2 mM) or in the presence of galactose (25 mM). Results are the average +/-S.E.M. of three independent experiments each performed in quadruplicate. b) Autophagic flux as determined by levels of p62 and the ratio of LC3I/LC3II. MEF cells were shifted to a low nutrient media (Hanks buffered salt solution; t=0) and subsequently assessed for markers of autophagic flux. Consistent with increased autophagic flux, starvation led to decreased levels of p62 and an increased LC3II/LC3I ratio. However, this response was similar between WT and in MCU -/-MEFs. A representative example from three similar experiments is shown. c) Similar assessment in vivo in both liver and heart tissues under randomly fed conditions. Again, no consistent differences were observed between genotypes. GAPDH is shown as a loading control.
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Figure S5: Regulation of skeletal muscle PDH phosphorylation by MCU. a) Measurement of matrix calcium levels under fed conditions reveals that the differences between WT and in MCU -/-mitochondria are less pronounced then under fasting conditions (n=3 mice per genotype). b) Mice were fasted overnight, re-fed and then harvested four hours later. Phosphorylation of serine 293 of skeletal muscle PDH E1-α subunit was determined. c) Densitometric quantification of the intensity of phosphorylated to total PDH was determined. n=3; p=NS. d) Isolated skeletal muscle mitochondria were analyzed in the absence or presence of extramitochondrial calcium (500 µM for 1 minute). Calcium addition led to a brisk reduction in PDH phosphorylation in WT skeletal muscle mitochondria but this effect was not observed in MCU -/-mitochondria. PDH phosphorylation was determined by a phospho-specific antibody.
e) Analysis of citrate synthase activity in WT and in MCU -/-skeletal muscle mitochondria. n=3 mice per genotype, p=NS by t-test, all pooled data represents mean +/-S.E.M.
Supplementary Figure 5 Regulation of skeletal muscle PDH phosphorylation by MCU. a) Measurement of matrix calcium levels under fed conditions reveals that the differences between WT and in MCU -/-mitochondria are less pronounced then under fasting conditions (n=3 mice per genotype). b) Mice were fasted overnight, re-fed and then harvested four hours later. Phosphorylation of serine 293 of skeletal muscle PDH E1-α subunit was determined. c) Densitometric quantification of the intensity of phosphorylated to total PDH was determined. n=3; p=NS. d) Isolated skeletal muscle mitochondria were analyzed in the absence or presence of extramitochondrial calcium (500 µM for 1 minute). Calcium addition led to a brisk reduction in PDH phosphorylation in WT skeletal muscle mitochondria but this effect was not observed in MCU -/-mitochondria. PDH phosphorylation was determined by a phospho-specific antibody. e) Analysis of citrate synthase activity in WT and in MCU -/-skeletal muscle mitochondria. n=3 mice per genotype, p=NS by t-test, all pooled data represents mean +/-S.E.M. Cytochrome C release was similar in magnitude and kinetics between WT and MCU -/-cells. Tubulin is shown as a loading control. c) Measurement of cytosolic calcium using Fluo-4AM fluorescence in primary MEF cells following the addition of 2 mM hydrogen peroxide. Cells were analyzed at the indicated times by flow cytometry. While calcium levels rose after hydrogen peroxide, no discernable differences were observed between genotypes.
